Breaking News

Pharmaseal Offers No Cost Support for COVID-19 Clinical Trials

Will offer the Engility clinical trials management system at no cost for COVID-19 coronavirus clinical trials

By: Contract Pharma

Contract Pharma Staff

Pharmaseal International, a provider of clinical trials management systems, said that it will offer the Engility CTMS solution at no cost for COVID-19 coronavirus clinical trials. The free offer to utilize Engility CTMS is open to biopharmaceutical organizations and academic institutions.   Engility CTMS is cloud-based, with rapid implementation and can be used to manage the full lifecycle of clinical trials including associated regulatory documentation.   Engility CTMS allows companies to centr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters